Zynex, Inc. - Common Stock (ZYXI)

Zynex Inc (ZYXI) missed Q2 2025 revenue and EPS estimates, reporting $22.29M and a $0.32 loss. Shares dropped 11.66% amid growth concerns.

Discover the top movers in Thursday's after-hours session and stay informed about the post-market dynamics.

Let's have a look at what is happening on the US markets before the opening bell on Friday. Below you can find the top gainers and losers in today's pre-market session.

Intrigued by the market activity one hour before the close of the markets on Wednesday? Uncover the key winners and losers of today's session in our insightful analysis.

Looking for insights into the US markets in the middle of the day on Wednesday? Delve into the top gainers and losers of today's session and gain valuable market intelligence.

The session on Wednesday is off to an intriguing start with several stocks showing significant price gaps. Let's examine the gap up and gap down stocks in today's session.

Wondering what's happening in Monday's pre-market session? Find an overview in this article.

Let's explore the current happenings on the US markets on Tuesday. Below, you'll find the stocks exhibiting unusual volume in today's session.

On Monday, there are stocks with unusual volume. Let's take a look.

Let's have a look at what is happening on the US markets on Thursday. Below you can find the stocks with an unusual volume in today's session.

Building Momentum: Zynex Inc.’s (NASDAQ: ZYXI) Steady Rise in the Pain Management Market